Genetic markers of treatment response to tumour necrosis factor-α inhibitors in the treatment of psoriasis

Abstract

Using the candidate gene approach to identify biomarkers of treatment response in psoriasis may have limited utility. This was a small study with limited power. Future larger studies are needed to further examine these findings and to explore alternative approaches to identify predictors of treatment response to biological agents.